Peripheral Intravascular Ultrasound (IVUS) Market Size, Share & Trends Analysis | Global | 2025-2032 | MedCore

Global Peripheral Intravascular Ultrasound Market Report to 2032

The global peripheral intravascular ultrasound market was valued at over $240 million in 2025. It is expected to grow at a compound annual growth rate of 6.9%, reaching $383 million by 2032.

Peripheral intravascular ultrasound, also known as peripheral IVUS, is used during interventional procedures to provide real-time imaging from inside the vessel. This allows physicians to better assess vessel structures, support treatment planning, and optimize device placement.

Growth in this market is being driven by rising use of IVUS in venous treatments, increasing peripheral interventions, and the continued development of high-definition imaging technologies and miniaturized catheter systems.

Market adoption remains limited by the capital cost of IVUS consoles and the learning curve associated with interpreting IVUS images. Although IVUS provides valuable procedural guidance, uptake depends on facility budgets, physician training, and clinical comfort with the imaging platform.

Market Overview

The global peripheral intravascular ultrasound market includes disposable IVUS catheters and related console systems used in peripheral vascular procedures. IVUS provides internal vessel imaging during intervention, helping clinicians visualize vessel structure, guide treatment decisions, and improve procedural outcomes.

Peripheral IVUS is especially relevant in complex cases where external imaging may not provide enough detail. By imaging from within the vessel, IVUS can help physicians assess vessel size, plaque burden, obstruction, lesion characteristics, and device placement more directly.

A major trend in the market is the development of high-definition imaging technologies and smaller catheter systems. These improvements support better visualization, improved navigation, and more informed decisions during peripheral interventions. As catheter designs improve, IVUS can be used across a broader range of vessel sizes and procedural needs.

The market is also being shaped by venous applications. Philips, the leading company in IVUS devices, has actively positioned IVUS in connection with venous treatments. Following positive VIDIO trial results, IVUS has become closely associated with procedures involving the inferior vena cava, common iliac, iliofemoral, and common femoral vein obstruction.

Market Drivers

Venous treatment adoption is one of the strongest drivers of the peripheral IVUS market. Philips has marketed its IVUS products alongside venous treatment workflows, helping establish IVUS as a key imaging tool in deep venous interventions. With penetration rates of IVUS use in deep venous treatments already over 50%, venous procedures are expected to support strong market growth.

Demographic factors are also driving demand for peripheral interventions. The prevalence of peripheral arterial disease increases among individuals aged 65 and older. As the global population ages, PAD prevalence is expected to rise, increasing the number of peripheral vascular procedures and supporting higher IVUS catheter unit sales.

The continued development of high-definition imaging and miniaturized catheter systems is also expanding the role of peripheral IVUS. Better visualization and improved catheter navigation allow physicians to make more informed decisions during interventional procedures. These improvements are especially important in complex peripheral cases where accurate vessel assessment and optimized treatment placement can influence outcomes.

Market Limiters

Capital equipment cost remains a major barrier to adoption. An IVUS system requires both disposable IVUS catheters and an IVUS console. Popular IVUS consoles include Philips' Core(R) and Core(R) Mobile platforms. For cost-sensitive facilities, the upfront investment in the console can limit adoption and reduce catheter unit sales.

Image interpretation is another barrier. IVUS images can be difficult for untrained users to interpret because they may appear grainy and less immediately clear than some other imaging methods. Physicians often need training and repeated use before they become comfortable applying IVUS in regular practice.

Although the training process is not considered difficult, it still creates friction during early adoption. Compared with developing imaging techniques that may provide cleaner and more intuitive images, IVUS may become less preferred in some settings if physicians or facilities do not see enough clinical value to justify the learning curve and equipment cost.

Market Coverage and Data Scope

Quantitative coverage includes market size, market shares, procedure numbers, market forecasts, market growth rates, units sold, and average selling prices.

Qualitative coverage includes market drivers and limiters, competitive analysis, recent mergers and acquisitions, company profiles, product portfolios, leading competitors, and market growth trends.

The report includes unit sales, average selling prices, procedure numbers, market size, market growth trends, market forecasts through 2032, and historical data back to 2022.

• The analysis evaluates the global peripheral intravascular ultrasound market across seven major geographical regions: North America, Latin America, Western Europe, Central and Eastern Europe, the Middle East, Asia-Pacific, and Africa.

For each region, the report provides market valuation, unit analysis, and ASP assessment. This allows readers to compare procedural demand, pricing trends, adoption patterns, and competitive dynamics across mature and emerging markets.

The report is designed to help users understand how catheter unit sales, console adoption, procedure growth, and physician preference affect the global peripheral IVUS market. Market revenue is assessed using unit sales and average selling prices, supported by procedure-based forecasting through 2032.

Markets Covered and Segmentation

Peripheral Intravascular Ultrasound Market

• Product type:
• Peripheral IVUS catheters
• IVUS console systems

The peripheral IVUS catheter market includes disposable catheters used during peripheral vascular procedures to generate intravascular imaging. These catheters are used in both arterial and venous procedures, depending on vessel size, access route, and clinical need.

The IVUS console segment includes imaging platforms that connect with compatible IVUS catheters. Console placement can influence long-term catheter usage because facilities with installed systems are more likely to purchase disposable catheters for recurring procedures.

Peripheral IVUS adoption is also influenced by indication type. Venous treatments are a major area of growth, while peripheral arterial disease procedures remain important due to aging demographics and increasing peripheral intervention volumes.

Each segment is analyzed by market size, market share, procedure numbers, market forecasts, market growth rates, units sold, and average selling prices.

This segmentation helps show how device compatibility, clinical indication, facility investment, and physician training shape demand in the global peripheral IVUS market.

Competitive Analysis

Philips led the global peripheral IVUS market in 2025, supported by its broad catheter portfolio and strong position in venous indications. The company offers several peripheral IVUS catheter models, including Visions(R) PV .018, Visions(R) PV .035, Visions(R) PV .014P, and Visions(R) PV .014P RX.

Philips also offers Eagle Eye Platinum and Eagle Eye Platinum ST IVUS catheters, which are used in both coronary and peripheral procedures. These catheters are compatible with Philips' Core(R) and Core(R) Mobile IVUS consoles, giving the company a connected catheter and console ecosystem.

A key advantage for Philips is its phased-array IVUS catheter technology. Compared with rotational IVUS catheters, phased-array designs can support a simpler workflow and easier use during procedures. Philips also stands out as the only provider with a comprehensive IVUS catheter range covering 0.014", 0.018", and 0.035" peripheral IVUS catheters.

Boston Scientific ranked second in the peripheral IVUS catheter market in 2025. Its position is supported by the OptiCross18(R) peripheral IVUS catheter, which is compatible with the iLab(R) and POLARIS(TM) systems. Boston Scientific has particular strength in peripheral arterial disease indications due to its broader peripheral device portfolio and complementary products.

However, Boston Scientific faces more pressure in the venous market, where Philips has stronger catheter sizing coverage and a more established position. As venous IVUS use continues to grow, Philips is expected to remain highly competitive, while Boston Scientific's growth will depend on peripheral arterial disease demand and its ability to address catheter portfolio gaps.

Technology and Practice Trends

• High-definition imaging: Continued imaging improvements are helping physicians visualize vessel structures with more detail during peripheral interventions.
• Miniaturized catheter systems: Smaller catheter designs support improved navigation and broader use across different vessel sizes and procedure types.
• Venous treatment integration: IVUS is increasingly associated with deep venous interventions, especially procedures involving the inferior vena cava, common iliac, iliofemoral, and common femoral veins.
• PAD procedure support: As PAD-related interventions increase, IVUS catheter use is expected to benefit from higher peripheral procedure volumes.
• Phased-array IVUS technology: Philips' phased-array catheter approach supports workflow simplicity compared with rotational IVUS catheter systems.
• Catheter and console ecosystems: Compatibility between disposable catheters and installed console platforms remains important for purchasing decisions and long-term adoption.
• Physician training: IVUS use depends on physician comfort with image interpretation, making training and repeated procedural experience important to market growth.

These trends show that the global peripheral IVUS market is moving toward better image quality, more flexible catheter options, and greater use in complex peripheral interventions. At the same time, adoption will remain tied to facility investment, console availability, and physician confidence.

Geography

This report provides global coverage across North America, Europe, Asia-Pacific, Latin America, the Middle East, and Africa.

Why This Report

• How large is the global peripheral intravascular ultrasound market, and how fast is it expected to grow through 2032?
• What is driving IVUS adoption in venous treatments and peripheral vascular interventions?
• How are aging demographics and rising PAD prevalence affecting peripheral IVUS catheter unit sales?
• Why are high-definition imaging and miniaturized catheter systems important to future market growth?
• How do capital equipment costs affect IVUS adoption across cost-sensitive facilities?
• Why does image interpretation remain a barrier for new IVUS users?
• Which companies lead the global peripheral IVUS market, and what products support their competitive positions?
• How do catheter sizing options, console compatibility, and clinical indication mix shape competition?

The Global Peripheral Intravascular Ultrasound Market Report from iData Research helps manufacturers, investors, distributors, and strategy teams understand where demand is growing, how venous and PAD-related procedures are affecting adoption, and how catheter and console ecosystems influence market performance. It provides procedure-based market models, unit sales, ASPs, market forecasts, and competitive analysis to support planning across the global peripheral IVUS market.